Squamous intraepithelial lesions in seropositive HIV female patients. Their frecuency and association with cervical neoplasia risk-factors;Lesiones escamosas intraepiteliaes en pacientes VIH seropositivas. Su frecuencia y asociación con factores de riesgo para neoplasia cervical

Ginecologia y Obstetricia de Mexico

Volumn 71, Issue JAN., 2003, Pages 32-43

  Suárez Rincón, Ángel Emilio ^a   Vázquez Valls, Eduardo ^a   Ramírez Rodríguez, Manuel ^a   Montoya Fuentes, Héctor ^a   Covarrubias Rodríguez, María de la Paz ^a   Sánchez Corona, José ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Cervical neoplasia; HIV; Squamous intraepithelial lesions

Indexed keywords

VIRUS DNA;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; CLINICAL ARTICLE; COLPOSCOPY; FEMALE; GENITAL SYSTEM EXAMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS CELL; SUPERINFECTION; T LYMPHOCYTE; TITRIMETRY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX EPITHELIUM; VAGINA DISEASE; VIRUS TRANSMISSION; VULVA DISEASE; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HIV SEROPOSITIVITY; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0037279580     PISSN: 03009041     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Schiffman MH, Bauer HM, Iloover RN, Glass AG, Cadelí DM, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-64.
2. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
3. Wright TC, Sun XW. Infección por virus del papiloma humano y neoplasias anogenitales en mujeres inmunodeficientes. Clin Gynecol Obstet Temas Actuales 1996; 4: 793-823.
4. Halpert R, Fruchter RG, Sedlis A, Butt K, Boyce JG, et al. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986; 68: 251-4.
5. Petry KU, Scheffel D, Bode U, Gabrysiak T, Kochel H, et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994; 57: 836-40.
6. Biggar RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am 1996; 10: 997-1010.
7. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-I (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999; 91: 226-36.
8. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 1343-9.
9. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 21: 33-41.
10. Sillman FH, Sedlis A. Anogenital papillomavirus infection and neoplasia in immunodeficient women. Obstet Clin North Am 1987; 14: 537-57.
11. Vermund SH, Kelley KF, Klein RS, Feingold AR, Schreiber K, et al. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1991; 165: 392-400.
12. Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW, and the New York Cervical Disease Study. Cervical Intraepithelial Neoplasia in Women Infected With Human Immunodeficiency Virus: Prevalence, Risk Factors, and Validity of Papanicolaou Smears. Obstet Gynecol 1994; 84: 591-7.
13. Sun XW, Ellerbrock TV, Lungu O, Chiasson MA, Bush TJ, et al. Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol 1995; 85: 680-6.
14. Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: Impact of infection with human immunodeficiency virus. Arch Ped Adolesc Med 2000; 154: 127-34.
15. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000; 283: 1031-7.
16. Volkow P, Rubí S, Lizano M, Carrillo A, Villar-Compte D, et al. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus. Gynecol Oncol 2001; 82: 27-31.
17. Minkoff H, Eisenberger-Matityahu D, Feldman J, Burk R, and Clarke L. Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol 1999; 180: 824-36.
18. Fruchter RO, Maiman M, Sedlis A, Bartley L, Camilien L, et al. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996; 87: 338-44.
19. Holcomb K, Matthews RP, Chapman JE, Abulafia O, Lee YC, et al. The efficacy of cervical conization in the treatment of cervical intraepithelial neoplasia in HIV-positive women. Gynecol Oncol 1999; 74: 428-31.
20. Wright TC, Koulos J, Schnoll F, Swanbeck J, Ellerbrock TV, et al. Cervical intraepithelial neoplasia in women infected with the human immunodeflciency virus: Outcome after loop electrosurgical excision. Gynecol Oncol 1994; 55: 253-8.
21. Fruchter RG, Maiman M, Sillman FH, Camilien L, Webber C, et al. Characteristics of cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus. Am J Obstet Gynecol 1994; 171: 531-7.
22. Petry KU, Kochel H, Bode U, Schedel I, Niester S, et al. Human papillomavirus is associated with the frequent detection of warty and basaloid high-grade neoplasia among immunocompromised women. Gynecol Oncol 1996; 60: 30-4.
23. Holcomb K, Maiman M, Dimaio T, Gates J. Rapid progression to invasive cervix cancer in a woman infected with the human immunodeficiency viruss. Obstet Gynecol 1998; 91: 848-50.
24. Maiman M, Fruchter RG, Clark M, Arrastia CD, Matthews R, et al. Cervical cancer as an AIDS-Defining illness. Obstet Gynecol 1997; 89: 76-80.
25. Centers for Disease Control. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 1992; 41 (No. RR-17): 1-19.
26. Compendio del Registro Histopatológico de Neoplasias en México. Morbilidad 1993-1995. Mortalidad 1990-1994. Dirección General de Epidemiología. Secretaría de Salud. 1997.
27. Del Río-Zolezzi A, Liguori A, Magis-Rodríguez C, Valdespino-Gómez JL, García-García ML, et al. La epidemia de VIH/SIDA y la mujer en México. Salud Publ Mex 1995; 37: 581-91.
28. Gómez-Estrada H, Vázquez-Escobosa C. Method of separation of lymphocytes from peripheral blood by means of a mixture of Ficoll and Angio-Conray. Arch Invest Med 1982; 13: 85-6.
29. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. En: Innis MA, Gelfand DH, Sninsky JJ, White TJ. PCR protocols: A guide to methods and applications. San Diego: Academic Press Inc, 1990: 153-8.
30. Maiman M, Tarricone N, Vieira J, Suarez J, Serur E, et al., Colposcopic evaluation of human immunodeflciency virus-seropositive women. Obstet Gynecol 1991; 78: 84-8.
31. Hankins C, Coutlee F, Lapointe N, Simard P, Tran T, et al. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Can Med Asoc J 1999; 160: 185-91.
32. Ho GY, Bierman R, Beardsley L, Chang C, Burk R. Natural historu of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-8.
33. Franco EL, Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus as a necessary cause of cervical cancer. J Natl Cancer Inst 1999; 91: 506-11.
34. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365-71.
35. Johnson JC, Burnett AF, Willet GD, Young MA, Doniger J. High frequency of latent and clinical cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 1992; 79: 321-7.
36. Lazcano-Ponce EC, Moss S, Alonso P, Salmerón CJ, Hernández AM. Cervical cancer screening in developing countries: Why is it ineffective? The case of Mexico. Arch Med Res 1999; 30: 240-50.
37. Fink MJ, Fruchter RG, Maiman M, Kelly P, Sedlis A, et al. The adequacy of cytology and colposcopy in diagnosing cervical neoplasia in HIV-seropositive women. Gynecol Oncol 1994; 55: 133-7.
38. Korn AP, Autry M, DeRemer PA, Tan W. Sensitivity of the Papanicolaou smear in human immunodeficiency virus-infected women. Obstet Gynecol 1994; 83: 401-4.
39. Del Priori G, Maag T, Bhattacharya M, Garcia PM, Till M, et al. The value of cervical cytology in HIIV-infected women. Gynecol Oncol 1995; 56: 395-8.
40. Robinson WR, Bames SE, Adams S, Perrin MS. Histology/Cytology discrepancies in HIV-infected obstetric patients with normal Pap smears. Gynecol Oncol 1997; 65: 430-3.
41. Goodman A, Chaudhuri PM, Tobin-Enos NJ, Hutchinson ML. The false negative rate of cervical smears in high risk HIV seropositive and seronegative women. Int Gynecol Cancer 2000; 10: 27-32.
42. Centers for Disease Control: Sexually transmitted diseases treatment guidelines. MMWR 1993; 42(44-14): 83-91.
43. Goldie SJ, Weinstein MC, Kuntz KM, and Freedberg KA. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med 1999; 130: 97-107.
44. Lazcano-Ponce EC, Alonso P, López L, Nájera P, Avila R, et al. Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centres in México. Acta Cytol 1997; 41: 277-84.